Treatment of osteoporosis among older adults discharged from hospital in Italy

被引:29
作者
Onder, G
Pedone, C
Gambassi, G
Landi, F
Cesari, M
Bernabei, R
机构
[1] Wake Forest Univ, Baptist Med Ctr, Sticht Ctr Aging, Sect Gerontol & Geriatr, Winston Salem, NC 27157 USA
[2] Univ Sacred Heart, Ctr Med Invecchiamento, I-00168 Rome, Italy
[3] Brown Univ, Ctr Gerontol & Hlth Care Res, Providence, RI 02912 USA
关键词
osteoporosis; elderly; epidemiology;
D O I
10.1007/s002280100370
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: Osteoporosis and its complications represent one of the most important causes of morbidity and mortality among the elderly. Despite the availability of several drugs deemed effective at reducing the incidence of fractures, only a minority of patients receive pharmacological treatment. We studied patients with a diagnosis of osteoporosis at discharge from hospital in Italy to identify predictors of receiving specific pharmacological treatment and to analyse how the pattern of drug prescription has changed in the last decade. Methods: We analysed data from a multicentre pharmacoepidemiology study that collected data on hospitalised patients throughout Italy. Patients with a diagnosis of osteoporosis admitted during five different surveys in 1988, 1991, 1993, 1995 and 1997 were considered for the present study. Results: Of 863 patients with a diagnosis of osteoporosis, 461 (53.4%) received treatment. Age [odds ratio (OR) 0.86 for each decade of increment, 95% confidence interval (CI) 0.73, 0.99], male gender (OR 0.67, 95% CI 0.44, 0.99), number of comorbid conditions (4-5 vs 0-3 conditions: OR 0.66, 95% Cl 0.47, 0.91; 6 or more vs 0-3 conditions: OR 0.47, 95% Cl 0.31, 0.72) and number of medications (OR 0.92 for each drug increase, 95% Cl 0.85, 0.99) were all associated with a reduced likelihood of receiving pharmacological treatment for osteoporosis. In contrast, concomitant corticosteroid use (OR 2.00, 95% CI 1.05, 3.80), admission for hip or vertebral fracture (OR 2.10, 95% Cl 1.12, 3.93) and year of survey (OR 1.11, 95% Cl 1.01, 1.24) were independent predictors of a higher treatment rate. Among individual drugs, calcitonin use remarkably declined from 42.1% in 1988 to 0.8% in 1997 (P for trend <0.001), while bisphosphonate prescriptions increased from 1.3% in 1988 to 34.9% in 1997 (P for trend <0.001). Prescription of calcium did not chancre significantly throughout the decade examined, while vitamin D had a twofold increase (14.2% in 1988 to 26.2% in 1997, P for trend <0.001). Conclusions: Among patients discharged from hospital in Italy, osteoporosis is an uncommon diagnosis. Even when the diagnosis is made, osteoporosis is often undertreated, and treatment is reserved for younger and less medically complex patients.
引用
收藏
页码:599 / 604
页数:6
相关论文
共 33 条
[1]   Androgen supplementation in eugonadal men with osteoporosis - Effects of 6 months of treatment on bone mineral density and cardiovascular risk factors [J].
Anderson, FH ;
Francis, RM ;
Faulkner, K .
BONE, 1996, 18 (02) :171-177
[2]  
[Anonymous], 1980, INTERNATIONAL Classification of Diseases
[3]   THE EFFECT OF TREATMENT WITH CALCITONIN ON VERTEBRAL FRACTURE RATE IN OSTEOPOROSIS [J].
BURCKHARDT, P ;
BURNAND, B .
OSTEOPOROSIS INTERNATIONAL, 1993, 3 (01) :24-30
[4]   IS AGE AN INDEPENDENT RISK FACTOR OF ADVERSE DRUG-REACTIONS IN HOSPITALIZED MEDICAL PATIENTS [J].
CARBONIN, P ;
PAHOR, M ;
BERNABEI, R ;
SGADARI, A .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1991, 39 (11) :1093-1099
[5]   Mortality after all major types of osteoporotic fracture in men and women: an observational study [J].
Center, JR ;
Nguyen, TV ;
Schneider, D ;
Sambrook, PN ;
Eisman, JA .
LANCET, 1999, 353 (9156) :878-882
[6]   VITAMIN-D(3) AND CALCIUM TO PREVENT HIP-FRACTURES IN ELDERLY WOMEN [J].
CHAPUY, MC ;
ARLOT, ME ;
DUBOEUF, F ;
BRUN, J ;
CROUZET, B ;
ARNAUD, S ;
DELMAS, PD ;
MEUNIER, PJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (23) :1637-1642
[7]   A CONTROLLED TRIAL OF THE EFFECT OF CALCIUM SUPPLEMENTATION ON BONE-DENSITY IN POSTMENOPAUSAL WOMEN [J].
DAWSONHUGHES, B ;
DALLAL, GE ;
KRALL, EA ;
SADOWSKI, L ;
SAHYOUN, N ;
TANNENBAUM, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (13) :878-883
[8]   The cost of treating osteoporotic fractures in the United Kingdom female population [J].
Dolan, P ;
Togerson, DJ .
OSTEOPOROSIS INTERNATIONAL, 1998, 8 (06) :611-617
[9]   Management of male osteoporosis: report of the UK Consensus Group [J].
Eastell, R ;
Boyle, IT ;
Compston, J ;
Cooper, C ;
Fogelman, I ;
Francis, RM ;
Hosking, DJ ;
Purdie, DW ;
Ralston, S ;
Reeve, J ;
Reid, DM ;
Russell, RGG ;
Stevenson, JC .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 1998, 91 (02) :71-92
[10]   Treatment of postmenopausal osteoporosis [J].
Eastell, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (11) :736-746